High-dose carboplatin and etoposide for salvage chemotherapy of germ cell tumours
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (5) , 717-723
- https://doi.org/10.1016/0959-8049(95)00018-e
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Escalating drug delivery in cancer chemotherapy: A review of concepts and practice —Part 2Annals of Oncology, 1993
- Increasing the Dose Intensity of Chemotherapy in Poor-Prognosis Metastatic Non-SeminomaEuropean Urology, 1993
- Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors.Journal of Clinical Oncology, 1992
- Carboplatin dose in combination chemotherapy for testicular cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.Journal of Clinical Oncology, 1989
- Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumoursEuropean Journal of Cancer and Clinical Oncology, 1989
- The Management of Advanced Testicular TeratomaBritish Journal of Urology, 1988
- Cyclophosphamide and VP 16-213 with autologous bone marrow transplantation. A dose escalation studyEuropean Journal of Cancer and Clinical Oncology, 1984
- High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study.Journal of Clinical Oncology, 1984